WO2001036459A3 - Novel use of hcc-2 - Google Patents

Novel use of hcc-2 Download PDF

Info

Publication number
WO2001036459A3
WO2001036459A3 PCT/EP2000/011274 EP0011274W WO0136459A3 WO 2001036459 A3 WO2001036459 A3 WO 2001036459A3 EP 0011274 W EP0011274 W EP 0011274W WO 0136459 A3 WO0136459 A3 WO 0136459A3
Authority
WO
WIPO (PCT)
Prior art keywords
hcc
novel use
stem cells
cells
inhibitor
Prior art date
Application number
PCT/EP2000/011274
Other languages
French (fr)
Other versions
WO2001036459A2 (en
Inventor
Wolf-Georg Forssmann
Reinhard Henschler
Rudolf Richter
Original Assignee
Forssmann Wolf Georg
Reinhard Henschler
Rudolf Richter
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forssmann Wolf Georg, Reinhard Henschler, Rudolf Richter filed Critical Forssmann Wolf Georg
Priority to AU25056/01A priority Critical patent/AU2505601A/en
Publication of WO2001036459A2 publication Critical patent/WO2001036459A2/en
Publication of WO2001036459A3 publication Critical patent/WO2001036459A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Use of HCC-2 as an inhibitor of stem cells, hematopoietic stem cells and/or progenitor cells.
PCT/EP2000/011274 1999-11-15 2000-11-15 Novel use of hcc-2 WO2001036459A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU25056/01A AU2505601A (en) 1999-11-15 2000-11-15 Novel use of hcc-2

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US16571799P 1999-11-15 1999-11-15
EP99122655 1999-11-15
US60/165,717 1999-11-15
EP99122655.6 1999-11-15

Publications (2)

Publication Number Publication Date
WO2001036459A2 WO2001036459A2 (en) 2001-05-25
WO2001036459A3 true WO2001036459A3 (en) 2001-11-15

Family

ID=26153166

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/011274 WO2001036459A2 (en) 1999-11-15 2000-11-15 Novel use of hcc-2

Country Status (2)

Country Link
AU (1) AU2505601A (en)
WO (1) WO2001036459A2 (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997012041A1 (en) * 1995-09-29 1997-04-03 Smithkline Beecham Corporation SHORT FORMS OF CHEMOKINE β-8
WO1997015594A1 (en) * 1995-10-24 1997-05-01 Smithkline Beecham Corporation Novel chemokine for mobilizing stem cells
WO1997021812A2 (en) * 1995-12-08 1997-06-19 Schering Corporation Mammalian chemokine ccf8 and chemokine receptor cckr3
WO1997041230A2 (en) * 1996-04-30 1997-11-06 Forssmann Wolf Georg Cc-type chemokines
EP0905240A1 (en) * 1997-09-29 1999-03-31 Applied Research Systems Ars Holding N.V. Amino-terminally truncated c-c chemokines as chemokine antagonists
WO1999028472A1 (en) * 1997-11-27 1999-06-10 Korea Green Cross Corporation A cDNA ENCODING C6 β-CHEMOKINE LEUKOTACTIN-1(Lkn-1) ISOLATED FROM HUMAN
WO2000073456A1 (en) * 1999-05-27 2000-12-07 Korea Green Cross Corporation A VARIANT OF C6 β-CHEMOKINE LEUKOTACTIN-1(shLkn-1) WITH ENHANCED BIOLOGICAL ACTIVITY

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997012041A1 (en) * 1995-09-29 1997-04-03 Smithkline Beecham Corporation SHORT FORMS OF CHEMOKINE β-8
WO1997015594A1 (en) * 1995-10-24 1997-05-01 Smithkline Beecham Corporation Novel chemokine for mobilizing stem cells
WO1997021812A2 (en) * 1995-12-08 1997-06-19 Schering Corporation Mammalian chemokine ccf8 and chemokine receptor cckr3
WO1997041230A2 (en) * 1996-04-30 1997-11-06 Forssmann Wolf Georg Cc-type chemokines
EP0905240A1 (en) * 1997-09-29 1999-03-31 Applied Research Systems Ars Holding N.V. Amino-terminally truncated c-c chemokines as chemokine antagonists
WO1999028472A1 (en) * 1997-11-27 1999-06-10 Korea Green Cross Corporation A cDNA ENCODING C6 β-CHEMOKINE LEUKOTACTIN-1(Lkn-1) ISOLATED FROM HUMAN
WO1999028473A1 (en) * 1997-11-27 1999-06-10 Korea Green Cross Corporation A cDNA ENCODING C6 β-CHEMOKINE LEUKOTACTIN-1(Lkn-1) ISOLATED FROM HUMAN
WO2000073456A1 (en) * 1999-05-27 2000-12-07 Korea Green Cross Corporation A VARIANT OF C6 β-CHEMOKINE LEUKOTACTIN-1(shLkn-1) WITH ENHANCED BIOLOGICAL ACTIVITY

Also Published As

Publication number Publication date
AU2505601A (en) 2001-05-30
WO2001036459A2 (en) 2001-05-25

Similar Documents

Publication Publication Date Title
AU2002319780A1 (en) Alternative compositions and methods for the culture of stem cells
EP2266396A3 (en) Modulation of stem cells using zinc finger proteins
EP1551953B8 (en) Modulation of stem and progenitor cell differentiation, assays, and uses thereof
WO2004029219A3 (en) Cell-based rna interference and related methods and compositions
AU2001251063A1 (en) 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
AU2001241078A1 (en) Alpha-amylase activity inhibitors
AU1741601A (en) Mesenchymal stem cells and/or progenitor cells, their isolation and use
AU2001280149A1 (en) Stem cell culture medium and culture method by using the same
AU6571700A (en) Enzymatic synthesis of deoxyribonucleosides
AU2003280687A1 (en) Composition for culturing multipotent stem cells and utilization of the same
AU2001269575A1 (en) Nucleic acid sequences and proteins involved in cellular senescence
AU5213300A (en) 2-nh-pyridones and pyrimidones as mrs inhibitors
AU2003287521A1 (en) Pluripotent cells from monocytes, and methods of making and using pluripotent cells
AU2003233222A1 (en) Aqueous polyurethane preparations
AU2002304249A1 (en) Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same
AU2002220697A1 (en) Isolated luciferases lu164, lual and lu22, and the use of the same
EP1726311A3 (en) Migration of hematopoietic stem cells and progenitor cells to the liver
AU2002303712A1 (en) Novel telomerase inhibitors and uses therefor
AU2002216223A1 (en) Preservation of cells
AU2001269730A1 (en) Low carbohydrate compositions, kits thereof, and methods of use
AU2003211367A1 (en) Novel dehydrogenase and gene encoding the same
AU2002218019A1 (en) Methods for depleting and isolating alloreactive and antigen-reactive t cells from hematopoietic donor cells
AU2001235938A1 (en) Method for increasing the performance of immobilized biocatalysts, and catalystsobtained thereby
WO2002031121A3 (en) Improvement of endothelial cell-cell cohesion
WO2001036459A3 (en) Novel use of hcc-2

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase